These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3997512)

  • 21. [Clinical and experimental studies on blood histamine levels in topical corticosteroid therapy].
    Tanaka K
    Nihon Hifuka Gakkai Zasshi; 1987 Feb; 97(2):125-36. PubMed ID: 2955146
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
    Halsos AM
    Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of induction of human contact sensitization by topical glucocorticosteroids.
    Burrows WM; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):175-8. PubMed ID: 962352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experiences with a new topical steroid].
    Meyer-Rohn J
    Z Hautkr; 1975; Suppl 2():3-6. PubMed ID: 1229217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
    Wendt H; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
    Täuber VU; Amin M; Fuchs P; Speck U
    Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of croton oil and cantharidin induced inflammations of the mouse ear and their modification by topically applied drugs.
    Swingle KF; Reiter MJ; Schwartzmiller DH
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):168-76. PubMed ID: 7337491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability and blanching potential of corticosteroid ointments.
    Kirsch ; Gibson JR
    J Clin Hosp Pharm; 1984 Jun; 9(2):143. PubMed ID: 6235247
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and safety of topical 0.05% diflorasone diacetate (florone) cream/ointment in patients with acute/chronic dermatitis].
    Schneider WD
    Z Hautkr; 1984 Oct; 59(19):1312, 1319-22. PubMed ID: 6391003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.
    Woodford R; Haigh JM; Barry BW
    Dermatologica; 1983; 166(3):136-40. PubMed ID: 6852325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
    Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
    J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
    Henschel V; Jaminet F
    J Pharm Belg; 1974; 29(1):3-15. PubMed ID: 4831715
    [No Abstract]   [Full Text] [Related]  

  • 36. [Corticosteroid preparations with and without supplementary antibiotics. Comparison of fluclorolone acetonide (Topilar cream) and betamethasone valerate cream (Betnovat) with neomycin].
    Nielsen R; Thomsen K
    Ugeskr Laeger; 1979 Jul; 141(30):2046-9. PubMed ID: 531939
    [No Abstract]   [Full Text] [Related]  

  • 37. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are generic formulations equivalent to trade name topical glucocorticoids?
    Stoughton RB
    Arch Dermatol; 1987 Oct; 123(10):1312-4. PubMed ID: 3662563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.
    Olsen EA
    Arch Dermatol; 1991 Feb; 127(2):197-201. PubMed ID: 1990984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus.
    Theng CT; Tan SH; Goh CL; Suresh S; Wong HB; Machin D;
    J Dermatolog Treat; 2004 Jun; 15(3):141-5. PubMed ID: 15204145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.